Seyyedi Samaneh Sadat, Soleimani Masoud, Yaghmaie Marjan, Ajami Monireh, Ajami Mansoureh, Pourbeyranvand Shahram, Alimoghaddam Kamran, Akrami Seyed Mohammad
Department of Medical Genetics, Tehran University of Medical Sciences, International Campus (TUMS-IC), Tehran, Iran.
Department of Hematology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Tumour Biol. 2016 Apr;37(4):4841-7. doi: 10.1007/s13277-015-4289-y. Epub 2015 Nov 2.
Cytogenetically normal acute myeloid leukemia (CN-AML) constitutes the largest subgroup of AML patients that is associated with molecular alteration. MiRNAs have been shown to be aberrantly expressed in CN-AML. In addition, specific miRNA (miR) expression patterns were found to be associated with certain genetic alterations in these patients. This study investigated the expression level of miR-1, miR-486, and let-7a in 45 CN-AML patients well characterized for FLT3 and/or NPM1 mutations using real-time quantitative RT-PCR and evaluated the association between candidate miRs expression and clinical features. Our data revealed that miR-1 was significantly overexpressed in CN-AML patients, and increasing expression of miR-1 correlated with NPM1 mutation (P < 0.05) and lower hemoglobin level was also observed in patients with miR-1 overexpression (P < 0.05). The expression of miR-1 was much higher in AML-M2 compared with other subtypes. Further, we found significantly increasing miR-486 expression in 40 of 45 (89 %) CN-AML patients. There was no significant association of upregulation of miR-486 with clinical parameters. The expression level of miR-486 was increased in AML-M2 subtype. The levels of let-7a were significantly increased in CN-AML patients compared to the healthy control and significantly higher in the NPM1 ± CN-AML patients. There was no correlation detected between the level of let-7a and FLT3+. An increasing expression level of let-7a was demonstrated in M2 subtype. In addition, our data showed no significant association between increasing let-7a and clinical characteristic. Comparison of peripheral blood and bone marrow results in 30 CN-AML patients showed that there is a considerable concordance between PB and BM in the results of candidate miR levels (P < 0.001). In conclusion, further studies should also be performed to detect functional mechanism of these miRs.
细胞遗传学正常的急性髓系白血病(CN-AML)是与分子改变相关的最大的AML患者亚组。已证明miRNA在CN-AML中表达异常。此外,发现特定的miRNA(miR)表达模式与这些患者的某些基因改变相关。本研究使用实时定量RT-PCR调查了45例具有FLT3和/或NPM1突变特征明确的CN-AML患者中miR-1、miR-486和let-7a的表达水平,并评估了候选miR表达与临床特征之间的关联。我们的数据显示,miR-1在CN-AML患者中显著过表达,miR-1表达增加与NPM1突变相关(P<0.05),并且在miR-1过表达的患者中也观察到较低的血红蛋白水平(P<0.05)。与其他亚型相比,AML-M2中miR-1的表达要高得多。此外,我们发现45例CN-AML患者中有40例(89%)miR-486表达显著增加。miR-486上调与临床参数无显著关联。AML-M2亚型中miR-486的表达水平升高。与健康对照相比,CN-AML患者中let-7a的水平显著升高,在NPM1±CN-AML患者中显著更高。未检测到let-7a水平与FLT3+之间的相关性。M2亚型中let-7a的表达水平升高。此外,我们的数据显示let-7a增加与临床特征之间无显著关联。对30例CN-AML患者的外周血和骨髓结果进行比较,结果显示候选miR水平的外周血和骨髓结果之间存在相当大的一致性(P<0.001)。总之,还应进行进一步研究以检测这些miR的功能机制。